Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy

Hematologic cancer (mainly myelodysplastic syndrome) developed in 7 of 67 patients with cerebral adrenoleukodystrophy 14 to 92 months after receipt of gene therapy.

​   The New England Journal of Medicine: Search Results in Neurology/Neurosurgery